Annual Working Capital
$4.90 M
-$2.49 M-33.65%
December 31, 2023
Summary
- As of February 7, 2025, PCSA annual working capital is $4.90 million, with the most recent change of -$2.49 million (-33.65%) on December 31, 2023.
- During the last 3 years, PCSA annual working capital has fallen by -$10.08 million (-67.28%).
- PCSA annual working capital is now -71.76% below its all-time high of $17.36 million, reached on December 31, 2021.
Performance
PCSA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$3.62 M
-$2.31 M-38.93%
September 30, 2024
Summary
- As of February 7, 2025, PCSA quarterly working capital is $3.62 million, with the most recent change of -$2.31 million (-38.93%) on September 30, 2024.
- Over the past year, PCSA quarterly working capital has dropped by -$5.17 million (-58.83%).
- PCSA quarterly working capital is now -84.57% below its all-time high of $23.45 million, reached on March 31, 2021.
Performance
PCSA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PCSA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.6% | -58.8% |
| 3 y3 years | -67.3% | -51.0% |
| 5 y5 years | +256.6% | -51.0% |
PCSA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.8% | at low | -79.2% | at low |
| 5 y | 5-year | -71.8% | +2756.9% | -84.6% | +258.6% |
| alltime | all time | -71.8% | +308.5% | -84.6% | +245.3% |
Processa Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.62 M(-38.9%) |
| Jun 2024 | - | $5.93 M(-32.6%) |
| Mar 2024 | - | $8.79 M(+79.3%) |
| Dec 2023 | $4.90 M(-33.7%) | $4.90 M(-30.8%) |
| Sep 2023 | - | $7.08 M(-22.0%) |
| Jun 2023 | - | $9.08 M(-9.8%) |
| Mar 2023 | - | $10.06 M(+36.1%) |
| Dec 2022 | $7.39 M(-57.4%) | $7.39 M(-23.8%) |
| Sep 2022 | - | $9.69 M(-21.8%) |
| Jun 2022 | - | $12.39 M(-19.2%) |
| Mar 2022 | - | $15.33 M(-11.7%) |
| Dec 2021 | $17.36 M(+15.8%) | $17.36 M(-10.7%) |
| Sep 2021 | - | $19.44 M(-9.2%) |
| Jun 2021 | - | $21.40 M(-8.7%) |
| Mar 2021 | - | $23.45 M(+56.5%) |
| Dec 2020 | $14.98 M(-8220.2%) | $14.98 M(-756.5%) |
| Sep 2020 | - | -$2.28 M(+72.7%) |
| Jun 2020 | - | -$1.32 M(+48.5%) |
| Mar 2020 | - | -$889.80 K(+382.3%) |
| Dec 2019 | -$184.50 K(-113.4%) | -$184.50 K(-142.6%) |
| Sep 2019 | - | $433.50 K(+109.9%) |
| Jun 2019 | - | $206.50 K(-74.8%) |
| Mar 2019 | - | $818.20 K(-40.5%) |
| Dec 2018 | $1.37 M | $1.37 M(-34.9%) |
| Sep 2018 | - | $2.11 M(-28.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $2.94 M(-393.3%) |
| Mar 2018 | - | -$1.00 M(-385.4%) |
| Dec 2017 | $351.80 K(-115.0%) | $351.80 K(-1105.1%) |
| Sep 2017 | - | -$35.00 K(-98.6%) |
| Jun 2017 | - | -$2.49 M(+2.2%) |
| Mar 2017 | - | -$2.44 M(+3.7%) |
| Dec 2016 | -$2.35 M(+18.8%) | -$2.35 M(+4.5%) |
| Sep 2016 | - | -$2.25 M(+3.6%) |
| Jun 2016 | - | -$2.17 M(+2.5%) |
| Mar 2016 | - | -$2.12 M(+7.0%) |
| Dec 2015 | -$1.98 M(+329.5%) | -$1.98 M(+12.1%) |
| Sep 2015 | - | -$1.77 M(+9.4%) |
| Jun 2015 | - | -$1.61 M(+31.8%) |
| Mar 2015 | - | -$1.22 M(+165.8%) |
| Dec 2014 | -$460.80 K(-24.1%) | -$460.80 K(+12.7%) |
| Sep 2014 | - | -$408.90 K(+327.3%) |
| Jun 2014 | - | -$95.70 K(-68.7%) |
| Mar 2014 | - | -$306.20 K(-49.6%) |
| Dec 2013 | -$607.00 K(-237.5%) | -$607.00 K(<-9900.0%) |
| Sep 2013 | - | $3600.00(-100.3%) |
| Jun 2013 | - | -$1.43 M(+161.2%) |
| Mar 2013 | - | -$546.40 K(-223.8%) |
| Dec 2012 | $441.40 K(-82.2%) | $441.40 K(-67.4%) |
| Sep 2012 | - | $1.36 M |
| Dec 2011 | $2.47 M | - |
FAQ
- What is Processa Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual working capital year-on-year change?
- What is Processa Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly working capital year-on-year change?
What is Processa Pharmaceuticals annual working capital?
The current annual working capital of PCSA is $4.90 M
What is the all time high annual working capital for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual working capital is $17.36 M
What is Processa Pharmaceuticals annual working capital year-on-year change?
Over the past year, PCSA annual working capital has changed by -$2.49 M (-33.65%)
What is Processa Pharmaceuticals quarterly working capital?
The current quarterly working capital of PCSA is $3.62 M
What is the all time high quarterly working capital for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly working capital is $23.45 M
What is Processa Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, PCSA quarterly working capital has changed by -$5.17 M (-58.83%)